News Archive

LUNGevity is delighted that the Lung-MAP trial has launched this ambitious, strategic approach with non-small cell lung cancer, an area of great promise and great need. Collaboration in clinical trial design has the potential to dramatically increase the efficiency of recruiting patients and getting new treatment options to our lung cancer patient population more quickly.